Role of Homoeopathic Individualized Medicine in the management of Post Menopausal Syndrome

Role of Homoeopathic Individualized Medicine in the management of Post Menopausal Syndrome - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072378

Enrollment

Registered

2024-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: Individualised homoeopathic medicine: in globules/ sac lac in suitable potency (30c/200c/50 millicimal potency) based on criteria for potency selection of the patient, 1 dose-once 30

Eligibility

Inclusion criteria

Inclusion criteria: Females who have attained menopause and are above 45 are included Climacteric female suffering from postmenopausal syndrome are included Complications due to menopause are included

Exclusion criteria

Exclusion criteria: Females affected with other systemic and autoimmune illness are excluded Females undergone hysterectomy and oophorectomy are not included Female psychiatric illness is excluded

Design outcomes

Primary

Measure	Time frame
Change in clinical signs and symptoms Timepoint: Minimum period of 6 months and maximum period of 1 year	—

Secondary

Measure	Time frame
Reduction in The Menopause-Specific Quality of Life Questionnaire (MENQOL) Change in general wellbeing & mental state Timepoint: Minimum period of 6 months & maximum period of 1 year	—

Countries

India

Contacts

Public ContactMahalakshumi H

White Memorial Homoeopathic Medical College and Hospital

indusujan9495@gmail.com9495704030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026